Detalles de la búsqueda
1.
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia.
Cancer
; 130(2): 287-299, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801052
2.
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials.
Ann Hematol
; 102(6): 1375-1382, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37079069
3.
The multi-tyrosine kinase inhibitor ponatinib for chronic myeloid leukemia: Real-world data.
Eur J Haematol
; 105(1): 3-15, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32145037
4.
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.
Haematologica
; 104(8): 1589-1596, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30819917
5.
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
Ann Hematol
; 98(8): 1885-1890, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31044260
6.
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias.
Int J Mol Sci
; 20(24)2019 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31817063
7.
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia.
Am J Hematol
; 91(6): 617-22, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26971721
8.
A New Algorithm Integrating Molecular Response, Toxicity, and Plasma Level Measures for Ponatinib Dose Choice in Patients Affected by Chronic Myeloid Leukemia.
Pharmaceutics
; 16(3)2024 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38543276
9.
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells.
Blood
; 117(12): 3353-62, 2011 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-21278353
10.
SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia.
Blood
; 118(13): 3634-44, 2011 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-21821701
11.
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population.
Blood
; 118(17): 4554-60, 2011 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-21750313
12.
Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy.
Ther Adv Hematol
; 14: 20406207231190683, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37693118
13.
Clinical and Psychological Factors to Consider in Achieving Treatment-Free Remission in Patients With Chronic Myeloid Leukemia.
Front Oncol
; 11: 631570, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33777785
14.
Adherence, persistence and efficacy of dasatinib and nilotinib in the treatment of patients resistant or intolerant to imatinib with chronic myeloid leukemia in chronic phase: an Italian multicenter study over two years in real life.
Curr Med Res Opin
; 37(3): 477-481, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33459083
15.
Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome.
Cancers (Basel)
; 13(6)2021 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33804056
16.
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia.
Blood
; 112(5): 1876-85, 2008 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18591381
17.
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation.
J Clin Med
; 9(11)2020 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33213044
18.
Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
Ann Hematol
; 88(2): 151-8, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18709502
19.
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP.
Blood Adv
; 3(24): 4280-4290, 2019 12 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31869412
20.
Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate.
Leuk Res
; 32(2): 255-61, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17692911